The FDA recalled 62 million diabetic blood glucose test papers because the blood glucose readings were not correct
-
Last Update: 2013-08-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The U.S Food and Drug Administration (FDA) has warned diabetics that a batch of up to 62 million test papers used to measure blood sugar levels will be recalled because they will show incorrect blood sugar readings According to NBC on Wednesday, Nova diabetes care announced Friday that it would recall the batch of test papers, and incorrect readings would increase the risk of patients misusing drugs The products involved in the recall also include test papers that have been sold to the United States, Canada, Chile, Peru, Argentina, Dominican Republic, Jamaica and other regions, the report said The FDA said Wednesday that the test paper's readings were disturbed by contamination from chemicals in the manufacturing process FDA is working with the company to investigate the issue In addition, doctors and patients should also pay attention to the symptoms of hyperglycemia or hypoglycemia, including excessive thirst, nausea, fatigue, headache, shivering, etc.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
